Targeted Mutation Profiling of Non-Small Cell Lung Cancer Samples using the Sequenom Lungcarta™ Panel for Clinical Research
30 May 2013

Lung cancer is a highly heterogeneous disease and more biologically complex than previously thought. As cancer researchers further characterize individual tumors based on molecular profiles, it is essential to interrogate more than a single gene at a time. In this application note it is demonstrated that the LungCarta Panel provides a targeted, mid-density research panel for cost-effective and rapid analysis. Key somatic mutations in previously annotated genes and pathways such as EGFR, KRAS, and BRAF can be rapidly confirmed against larger sample numbers.

Download this Article

    Popular tags in SelectScience